Allogene Therapeutics, Inc. (ALLO)

Allogene Therapeutics Statistics

Total Valuation

ALLO has a market cap or net worth of $441.36 million. The enterprise value is $230.79 million.

Market Cap	441.36M
Enterprise Value	230.79M

Important Dates

The last earnings date was Thursday, November 7, 2024, after market close.

Earnings Date	Nov 7, 2024
Ex-Dividend Date	n/a

Share Statistics

ALLO has 209.67 million shares outstanding. The number of shares has increased by 22.14% in one year.

Current Share Class	209.67M
Shares Outstanding	209.67M
Shares Change (YoY)	+22.14%
Shares Change (QoQ)	+10.08%
Owned by Insiders (%)	8.13%
Owned by Institutions (%)	70.34%
Float	151.87M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	7,781.73
PB Ratio	0.93
P/TBV Ratio	0.91
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	5,367.16
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 9.35, with a Debt / Equity ratio of 0.20.

Current Ratio	9.35
Quick Ratio	9.04
Debt / Equity	0.20
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-2,688.56

Financial Efficiency

Return on equity (ROE) is -54.15% and return on invested capital (ROIC) is -27.19%.

Return on Equity (ROE)	-54.15%
Return on Assets (ROA)	-25.82%
Return on Capital (ROIC)	-27.19%
Revenue Per Employee	$185
Profits Per Employee	-$1.22M
Employee Count	233
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -30.51% in the last 52 weeks. The beta is 0.84, so ALLO's price volatility has been lower than the market average.

Beta (5Y)	0.84
52-Week Price Change	-30.51%
50-Day Moving Average	2.71
200-Day Moving Average	3.13
Relative Strength Index (RSI)	31.82
Average Volume (20 Days)	2,668,182

Short Selling Information

The latest short interest is 37.04 million, so 17.67% of the outstanding shares have been sold short.

Short Interest	37.04M
Short Previous Month	39.32M
Short % of Shares Out	17.67%
Short % of Float	24.39%
Short Ratio (days to cover)	20.05

Income Statement

In the last 12 months, ALLO had revenue of $43,000 and -$283.43 million in losses. Loss per share was -$1.54.

Revenue	43,000
Gross Profit	-201.95M
Operating Income	-268.86M
Pretax Income	-281.93M
Net Income	-283.43M
EBITDA	-254.97M
EBIT	-268.86M
Loss Per Share	-$1.54

Balance Sheet

The company has $291.56 million in cash and $92.52 million in debt, giving a net cash position of $199.04 million or $0.95 per share.

Cash & Cash Equivalents	291.56M
Total Debt	92.52M
Net Cash	199.04M
Net Cash Per Share	$0.95
Equity (Book Value)	463.75M
Book Value Per Share	2.21
Working Capital	271.84M

Cash Flow

In the last 12 months, operating cash flow was -$217.31 million and capital expenditures -$618,000, giving a free cash flow of -$217.93 million.

Operating Cash Flow	-217.31M
Capital Expenditures	-618,000
Free Cash Flow	-217.93M
FCF Per Share	-$1.04

Margins

Gross Margin	n/a
Operating Margin	-625,246.51%
Pretax Margin	-659,137.21%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-1,090,119.05%

Dividends & Yields

ALLO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-22.14%
Shareholder Yield	-22.14%
Earnings Yield	-66.92%
FCF Yield	-51.45%

Analyst Forecast

The average price target for ALLO is $10.06, which is 377.91% higher than the current price. The consensus rating is "Buy".

Price Target	$10.06
Price Target Difference	377.91%
Analyst Consensus	Buy
Analyst Count	12
Revenue Growth Forecast (5Y)	404.03%
EPS Growth Forecast (5Y)	-25.61%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ALLO has an Altman Z-Score of -2.4 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.4
Piotroski F-Score	3